N/A
N=265
Colorectal Cancer: Screening vs. Non-Screening
Colorectal Cancer · Screening
Bottom Line
View on ClinicalTrials.gov: NCT02727894 ↗Enrolled (actual)
265
Serious AEs
—
Results posted
Mar 2019
Primary outcome: Primary: Colorectal Cancer Stage (pTNM) — 46; 85 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Institute for Clinical and Experimental Medicine
- Primary completion
- Dec 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Colorectal Cancer Stage (pTNM) |
46; 85 | — |
| SECONDARY Colorectal Cancer Grade |
53; 120 | — |
| SECONDARY Colorectal Cancer Resection Margins |
48; 94 | — |
| SECONDARY Colorectal Cancer Metastasis |
55; 104 | — |
| SECONDARY Colorectal Cancer Surgery |
30; 21.5 | — |
| SECONDARY Colorectal Cancer and Palliative Therapy |
2; 23 | — |
Summary
The purpose of this study is to determine whether colorectal cancer diagnosed by screening (primary screening colonoscopy, colonoscopy after immunochemical based faecal occult blood test) has more favourable clinical-pathological characteristics than colorectal cancer diagnosed for symptoms. We aimed to compare these two groups of patients at the time of diagnosis and confirm the efficiency of the screening programme.
Eligibility Criteria
Inclusion Criteria
- newly diagnosed colorectal cancer
Exclusion Criteria
- unsigned informed consent
- mental disorder
Data sourced from ClinicalTrials.gov (NCT02727894). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.